1 jan 2014 ano - $100 million from Alexion Pharmaceuticals
Descrição:
Alexion Pharmaceuticals paid Moderna $100 million for ten product options to develop rare disease treatments, including for Crigler-Najjar syndrome, using Moderna's mRNA therapeutics platform
Adicionado na linha do tempo:
Data: